Cargando…
Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204
Cell type-specific drug delivery is a straightforward strategy to achieve targeted cancer therapy and reduce side effects. Hyaluronic acid (HA), an U.S. Food and Drug Administration (FDA)-approved biocompatible carbohydrate polymer, has been extensively employed as a targeting ligand for a drug deli...
Autores principales: | Li, Dan, Gong, Liang, Lin, Han, Yao, Surui, Yin, Yuan, Zhou, Zhifang, Shi, Jie, Wu, Zhimeng, Huang, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562169/ https://www.ncbi.nlm.nih.gov/pubmed/36231028 http://dx.doi.org/10.3390/cells11193065 |
Ejemplares similares
-
Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance
por: Yao, Surui, et al.
Publicado: (2020) -
Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy
por: del Pozo-Acebo, Lorena, et al.
Publicado: (2021) -
Intracellular Fate of Bovine Milk Exosomes in Murine Bone Marrow-Derived Macrophages
por: Khanam, Afsana, et al.
Publicado: (2022) -
Oral Administration of Bovine and Porcine Milk Exosome Alter miRNAs Profiles in Piglet Serum
por: Lin, Delin, et al.
Publicado: (2020) -
Identification of novel rheumatoid arthritis-associated MiRNA-204-5p from plasma exosomes
por: Wu, Long-Fei, et al.
Publicado: (2022)